Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.

<h4>Introduction</h4>In people living with HIV, adherence to antiretroviral therapy (ART) is essential for achieving and sustaining viral suppression and reducing mortality. In young people living with HIV, ART adherence and retention remain a challenge with unsatisfactory viral suppress...

Full description

Saved in:
Bibliographic Details
Main Authors: Agnes Bwanika Naggirinya, David B Meya, Maria Sarah Nabaggala, Grace Banturaki, Agnes Kiragga, Joseph Rujumba, Peter Waiswa, Rosalind Parkes-Ratanshi
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2024-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0308923&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850236503909728256
author Agnes Bwanika Naggirinya
David B Meya
Maria Sarah Nabaggala
Grace Banturaki
Agnes Kiragga
Joseph Rujumba
Peter Waiswa
Rosalind Parkes-Ratanshi
author_facet Agnes Bwanika Naggirinya
David B Meya
Maria Sarah Nabaggala
Grace Banturaki
Agnes Kiragga
Joseph Rujumba
Peter Waiswa
Rosalind Parkes-Ratanshi
author_sort Agnes Bwanika Naggirinya
collection DOAJ
description <h4>Introduction</h4>In people living with HIV, adherence to antiretroviral therapy (ART) is essential for achieving and sustaining viral suppression and reducing mortality. In young people living with HIV, ART adherence and retention remain a challenge with unsatisfactory viral suppression rates despite facility-based intensive adherence counseling that is the standard of care. Few studies have evaluated mHealth adherence interventions among young people living with HIV in resource-limited settings.<h4>Methods</h4>This was a randomized parallel trial. Young people aged between15-24 living with HIV, initiating ART, or on ART for not more than 6 months at three ART clinics were recruited and randomized to a ratio of 1:1 to either standard of care or the intervention "Call for Life-Interactive Voice Response" with standard of care, between 12th August 2020 and 1st June 2022. The intervention is mobile technology-based software, that has interactive voice response functionalities, with a web-based interface, that allows interaction through the use of voice and tones via a dial pad. The primary outcome was viral suppression defined as HIV RNA below 1,000 copies per mL at 12 months with retention in care and viral suppression at month 6 as a secondary outcome. Descriptive statistics were used for participant characteristics. Primary outcomes and factors associated with viral load failure were assessed using the log-binomial model. All calculations were done using statistical software release 16.0.<h4>Results</h4>A total of 206 participants were recruited and randomized; the mean age was 22.5(SD±1.9) years and 81% (167/206) were female. The intervention had 78.6% (81/103), females, while the standard of care had 83.5% (86/103). Viral suppression at 12 months in the intervention arm was 73.6% (67/91) versus 51.9% (40/77) in the standard of care arm, p=0.01. Retention in care was 88.4% (91/103) in the intervention vs. 74.7% (77/103) in the standard of care arm p=0.01.<h4>Conclusion</h4>This is the first study in Uganda to demonstrate that mHealth has the potential to improve medication adherence and retention in care among youth living with HIV in Uganda.<h4>Trial registration</h4>NCT04718974 Registry: clinical Trials.gov.
format Article
id doaj-art-582d499b6c164e8588e72e6e8a02ed95
institution OA Journals
issn 1932-6203
language English
publishDate 2024-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-582d499b6c164e8588e72e6e8a02ed952025-08-20T02:01:57ZengPublic Library of Science (PLoS)PLoS ONE1932-62032024-01-011911e030892310.1371/journal.pone.0308923Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.Agnes Bwanika NaggirinyaDavid B MeyaMaria Sarah NabaggalaGrace BanturakiAgnes KiraggaJoseph RujumbaPeter WaiswaRosalind Parkes-Ratanshi<h4>Introduction</h4>In people living with HIV, adherence to antiretroviral therapy (ART) is essential for achieving and sustaining viral suppression and reducing mortality. In young people living with HIV, ART adherence and retention remain a challenge with unsatisfactory viral suppression rates despite facility-based intensive adherence counseling that is the standard of care. Few studies have evaluated mHealth adherence interventions among young people living with HIV in resource-limited settings.<h4>Methods</h4>This was a randomized parallel trial. Young people aged between15-24 living with HIV, initiating ART, or on ART for not more than 6 months at three ART clinics were recruited and randomized to a ratio of 1:1 to either standard of care or the intervention "Call for Life-Interactive Voice Response" with standard of care, between 12th August 2020 and 1st June 2022. The intervention is mobile technology-based software, that has interactive voice response functionalities, with a web-based interface, that allows interaction through the use of voice and tones via a dial pad. The primary outcome was viral suppression defined as HIV RNA below 1,000 copies per mL at 12 months with retention in care and viral suppression at month 6 as a secondary outcome. Descriptive statistics were used for participant characteristics. Primary outcomes and factors associated with viral load failure were assessed using the log-binomial model. All calculations were done using statistical software release 16.0.<h4>Results</h4>A total of 206 participants were recruited and randomized; the mean age was 22.5(SD±1.9) years and 81% (167/206) were female. The intervention had 78.6% (81/103), females, while the standard of care had 83.5% (86/103). Viral suppression at 12 months in the intervention arm was 73.6% (67/91) versus 51.9% (40/77) in the standard of care arm, p=0.01. Retention in care was 88.4% (91/103) in the intervention vs. 74.7% (77/103) in the standard of care arm p=0.01.<h4>Conclusion</h4>This is the first study in Uganda to demonstrate that mHealth has the potential to improve medication adherence and retention in care among youth living with HIV in Uganda.<h4>Trial registration</h4>NCT04718974 Registry: clinical Trials.gov.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0308923&type=printable
spellingShingle Agnes Bwanika Naggirinya
David B Meya
Maria Sarah Nabaggala
Grace Banturaki
Agnes Kiragga
Joseph Rujumba
Peter Waiswa
Rosalind Parkes-Ratanshi
Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
PLoS ONE
title Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
title_full Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
title_fullStr Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
title_full_unstemmed Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
title_short Effectiveness of interactive voice response-call for life mHealth tool on adherence to anti-retroviral therapy among young people living with HIV: A randomized trial in Uganda.
title_sort effectiveness of interactive voice response call for life mhealth tool on adherence to anti retroviral therapy among young people living with hiv a randomized trial in uganda
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0308923&type=printable
work_keys_str_mv AT agnesbwanikanaggirinya effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT davidbmeya effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT mariasarahnabaggala effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT gracebanturaki effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT agneskiragga effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT josephrujumba effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT peterwaiswa effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda
AT rosalindparkesratanshi effectivenessofinteractivevoiceresponsecallforlifemhealthtoolonadherencetoantiretroviraltherapyamongyoungpeoplelivingwithhivarandomizedtrialinuganda